Previous 10 | Next 10 |
home / stock / vyyrf / vyyrf news
2023-08-03 11:04:20 ET Voyageur Pharmaceuticals press release ( OTCPK:VYYRF ): Q2 GAAP EPS of -$0.51. Revenue of $4.85M (+583.1% Y/Y). Voyager had collaboration revenue of $4.9 million for the second quarter of 2023, compared to $0.7 million for the sam...
(TheNewswire) Calgary, Alberta - TheNewswire - August 1, 2023 - Voyageur Pharmaceuticals Ltd. ( TSX.V:VM ) ( USA: VYYRF ) (the " Company " or " Voyageur ") announces that it has filed its interim financial statements and management's discu...
(TheNewswire) Calgary, Alberta - TheNewswire - July 13, 2023 - Voyageur Pharmaceuticals Ltd. (TSX.V:VM) (USA:VYYRF) (the " Company " or " Voyageur ") announces that on July 10, 2023, it issued 383,360 Deferred Share Units ("DSUs") to directors of the ...
(TheNewswire) Calgary, Canada – TheNewswire - June 12, 2023 - Voyageur Pharmaceuticals Ltd . ( TSXV:VM ) ( USA : VYYRF) ("Voyageur" or the "Corporation"), a provider of innovative medical imaging solutions, is pleased to announce the release of the whi...
(NewsDirect) Voyageur Pharmaceuticals CEO Brent Willis joins Natalie Stoberman from the Proactive studios to discuss the successful completion of environmental and geotechnical field work assessment at its Frances Creek project site through its 100% owned subsidiary Voyageur Industrial Mi...
(NewsDirect) Proactive research analyst John Savin speaks to Thomas Warner after publishing a new research note on Voyageur Pharmaceuticals Ltd (TSX-V:VM, OTC:VYYRF), a Canadian company that specialises in transforming raw materials into pharmaceutical-grade contrast agents that can be us...
(TheNewswire) Calgary, AB - TheNewswire - May 31, 2023 - Voyageur Pharmaceuticals Ltd. ( TSXV:VM ) ( OTC :VYYRF) (" Voyageur " or the " Corporation ") announces the successful completion of environmental and geotechnical fi...
--News Direct-- Voyageur Pharmaceuticals CEO Brent Willis join's Proactive's Natalie Stoberman to share a significant licensing agreement with Rain Cage Carbon to develop nanocarbon-based contrast drugs for medical imaging. Willis says the partnership aims to develop new contrast agen...
--News Direct-- Click Image To View Full Size Calgary, Canada – TheNewswire - May 24, 2023 - Voyageur Pharmaceuticals Ltd. (TSXV:VM) (OTC:VYYRF) ("Voyageur" or the "Corporation"), announces it has entered into a groundbreaking development and license agreement with Rain C...
(TheNewswire) Calgary, AB - TheNewswire - April 28, 2023 - Voyageur Pharmaceuticals Ltd. (TSX.V:VM) (USA:VYYRF) (the " Company " or " Voyageur ") announces that it has filed its interim financial statements and management's discussion and anal...
News, Short Squeeze, Breakout and More Instantly...
Voyageur Minerals Ltd Company Name:
VYYRF Stock Symbol:
OTCMKTS Market:
Voyageur Minerals Ltd Website:
(TheNewswire) Calgary, Canada – TheNewswire - July 9, 2024 - Voyageur Pharmaceuticals Ltd . ( TSX.V: VM ) ( OTC : VYYRF) ("Voyageur" or the "Corporation") , a provider of innovative medical imaging solutions, announces that it has issued 435,925 De...
--News Direct-- Voyageur Pharmaceuticals CEO Brent Willis joined Steve Darling from Proactive to announce that the company and Rain Cage Carbon are advancing their collaboration following the first commercial creation of a V@C60 endohedral fullerene or Vanadium atom inside a C60 molecule....
(TheNewswire) Calgary, Alberta, Canada, June 11, 2024 – TheNewswire – Voyageur Pharmaceuticals Ltd . (TSX.V: VM) (USA: VYYRF) ("Voyageur" or the "Company") announces that in an innovative endeavor, Voyageur and Rain Cage Carbon Inc. ("Rain Cage") are fo...